Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Privia Health Group Inc. shares valued at $1,262,803 were sold by Morris Matthew Shawn on Mar 07. At $28.48 per share, Morris Matthew Shawn sold 44,340 shares. The insider’s holdings dropped to 121,739 shares worth approximately $3.45 million following the completion of this transaction.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Also, Morris Matthew Shawn sold 37,092 shares, netting a total of over 1,050,445 in proceeds. Following the sale of shares at $28.32 each, the insider now holds 121,739 shares.
Before that, Mehrotra Parth had sold 51,527 shares from its account. In a trade valued at $1,473,528, the President and COO traded Privia Health Group Inc. shares for $28.60 each. Upon closing the transaction, the insider’s holdings decreased to 51,527 shares, worth approximately $2.76 million.
As published in their initiating research note from Goldman on February 03, 2023, Privia Health Group Inc. [PRVA] has been a Buy and the price target has been revised to $32. This represents a 11.44% premium over Wednesday’s closing price. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in early December. As of December 08, 2022, UBS has initiated its “Buy” rating for PRVA.
Analyzing PRVA Stock Performance
On Wednesday, Privia Health Group Inc. [NASDAQ: PRVA] plunged -0.28% to $28.34. The stock’s lowest price that day was $27.91, but it reached a high of $28.61 in the same session. During the last five days, there has been a surge of approximately 0.35%. Over the course of the year, Privia Health Group Inc. shares have jumped approximately 24.79%. Shares of the company reached a 52-week high of $29.11 on 03/03/23 and a 52-week low of $20.64 on 01/06/23. A 50-day SMA is recorded $25.84, while a 200-day SMA reached $30.17. Nevertheless, trading volume fell to 0.5 million shares from 0.58 million shares the previous day.
Support And Resistance Levels for Privia Health Group Inc. (PRVA)
According to the 24-hour chart, there is a support level at 27.96, which, if violated, would cause prices to drop to 27.59. In the upper region, resistance lies at 28.66. The next price resistance is at 28.99. RSI (Relative Strength Index) is 60.18 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.42, which suggests the price will decrease in the coming days. Percent R is at 28.84%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
Is Privia Health Group Inc. subject to short interest?
Stocks of Privia Health Group Inc. saw a sharp rise in short interest on Jan 12, 2023 jumping by 0.32 million shares to 2.69 million. Data from Yahoo Finance shows that the short interest on Dec 14, 2022 was 2.37 million shares. A jump of 11.9% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.65 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.65.
Which companies own the most shares of Privia Health Group Inc. (PRVA)?
According to Goldman Sachs & Co. LLC filings, the company currently owns 24,824,591 shares, which is about 21.72% of the total PRVA shares outstanding. The investor’s shares have plunged by -3,187,612 from its previous 13-F filing of 28012203.0 shares. With the completion of the buy transaction, The Vanguard Group, Inc.’s stake is now worth $143,144,812. Newton Investment Management Nort reduced a -0.35% interest valued at $89.08 million while BlackRock Fund Advisors purchased a 790,334 stake. A total of 1,940,218 shares of Privia Health Group Inc. were bought by Millennium Management LLC during the quarter, and 18,752 were bought by T. Rowe Price Investment Manageme. In its current portfolio, Point72 Asset Management LP holds 1,979,918 shares valued at $53.54 million.
In terms of Privia Health Group Inc. share price expectations, FactSet research, analysts set an average price target of $39.13 in the next 12 months, up nearly 44.26% from the previous closing price of $28.42. Analysts anticipate Privia Health Group Inc. stock to reach $45.00 by 2023, with the lowest price target being $30.00. In spite of this, 16 analysts ranked Privia Health Group Inc. stock as a Buy at the end of 2023. On May 03, 2022, BofA Securities assigned a price target of “a Buy” to the stock and initiated coverage with a $27.